Smith & Nephew
SNN
$23.88
Share price
-2.81%
Change (1 day)
-25.12%
Change (1 year)
Categories
Smith & Nephew plc, also known as Smith+Nephew, is a British multinational medical equipment manufacturing company.
Operating Margin for Smith & Nephew (SNN)
Operating Margin as of April 2024 (TTM): 4.50%
According to Smith & Nephew 's latest financial reports and stock price the company's current Operating Margin is 4.50%. At the end of 2022 the company had an Operating Margin of 4.51%.
Operating Margin history for Smith & Nephew from 2001 to 2014
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 4.51% | -59.92% |
| 2021 | 11.24% | 108.41% |
| 2020 | 5.39% | -62.69% |
| 2019 | 14.46% | -9.2% |
| 2018 | 15.93% | -13.67% |
| 2017 | 18.45% | -18.9% |
| 2016 | 22.75% | 88.56% |
| 2015 | 12.06% | -22% |
| 2014 | 15.46% | -16.1% |
| 2013 | 18.43% | -30.68% |
| 2012 | 26.59% | 33.89% |
| 2011 | 19.86% | -12.09% |
| 2010 | 22.59% | 27.18% |
| 2009 | 17.76% | 19.71% |
| 2008 | 14.84% | 6.59% |
| 2007 | 13.92% | -29.66% |
| 2006 | 19.79% | 18.01% |
| 2005 | 16.77% | 16.13% |
| 2004 | 14.44% | -26.01% |
| 2003 | 19.52% | 20.02% |
| 2002 | 16.26% | 21.82% |
| 2001 | 13.35% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 22.88% | 408.44% | 🇺🇸 USA |
 Boston Scientific BSX | 11.27% | 150.44% | 🇺🇸 USA |
 Edwards Lifesciences EW | 31.50% | 600.00% | 🇺🇸 USA |
 Stryker Corporation SYK | 16.21% | 260.22% | 🇺🇸 USA |
 Orthofix Medical
OFIX | -2.90% | -164.44% | 🇺🇸 USA |
 CONMED CNMD | -6.77% | -250.44% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.